Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP715221.RA8MZByxfTy1SZ0uYQKJQVIwq-lBCna_m0GwCncOwOVv8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP715221.RA8MZByxfTy1SZ0uYQKJQVIwq-lBCna_m0GwCncOwOVv8130_assertion type Assertion NP715221.RA8MZByxfTy1SZ0uYQKJQVIwq-lBCna_m0GwCncOwOVv8130_head.
- NP715221.RA8MZByxfTy1SZ0uYQKJQVIwq-lBCna_m0GwCncOwOVv8130_assertion description "[The development of HTLV-1 associated clinical manifestations, such as TSP/HAM and ATLL, occur in 2-4% of the infected population and it is still unclear why this infection remains asymptomatic in most infected carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP715221.RA8MZByxfTy1SZ0uYQKJQVIwq-lBCna_m0GwCncOwOVv8130_provenance.
- NP715221.RA8MZByxfTy1SZ0uYQKJQVIwq-lBCna_m0GwCncOwOVv8130_assertion evidence source_evidence_literature NP715221.RA8MZByxfTy1SZ0uYQKJQVIwq-lBCna_m0GwCncOwOVv8130_provenance.
- NP715221.RA8MZByxfTy1SZ0uYQKJQVIwq-lBCna_m0GwCncOwOVv8130_assertion SIO_000772 19152396 NP715221.RA8MZByxfTy1SZ0uYQKJQVIwq-lBCna_m0GwCncOwOVv8130_provenance.
- NP715221.RA8MZByxfTy1SZ0uYQKJQVIwq-lBCna_m0GwCncOwOVv8130_assertion wasDerivedFrom befree-2016 NP715221.RA8MZByxfTy1SZ0uYQKJQVIwq-lBCna_m0GwCncOwOVv8130_provenance.
- NP715221.RA8MZByxfTy1SZ0uYQKJQVIwq-lBCna_m0GwCncOwOVv8130_assertion wasGeneratedBy ECO_0000203 NP715221.RA8MZByxfTy1SZ0uYQKJQVIwq-lBCna_m0GwCncOwOVv8130_provenance.